Last reviewed · How we verify

NCT06015555

TAMO Therapy Versus Postural Control Exercise in Children With Congenital Muscular Torticollis

Completed NA Last updated 29 August 2023
What this trial tests

NA trial testing TAMO in Torticollis Congenital in 18 participants. Completed in 1 July 2023.

Timeline
23 February 2023
Primary endpoint
25 June 2023
1 July 2023

Quick facts

Lead sponsorkhadija liaquat
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment18
Start date23 February 2023
Primary completion25 June 2023
Estimated completion1 July 2023
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

khadija liaquat

Who can join

Adults 3 Months to 6 Months, any sex, with Torticollis Congenital. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomized control trial was conducted through convenient sampling. 18 subjects were randomly allocated into two groups, group A received postural control exercises in addition to conventional therapy, while Group B received TAMO therapy along with conventional therapy. analysis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other khadija liaquat trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06015555.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing